{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:56:54Z","timestamp":1791874614220,"version":"4.3.4"},"reference-count":9,"publisher":"Centers for Disease Control MMWR Office","issue":"26","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm7226a3","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T14:43:38Z","timestamp":1688049818000},"page":"716-720","source":"Crossref","is-referenced-by-count":52,"title":["Hepatitis C Virus Clearance Cascade \u2014 United States, 2013\u20132022"],"prefix":"10.15585","volume":"72","author":[{"given":"Carolyn","family":"Wester","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ademola","family":"Osinubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey W.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Symum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"William A.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2023,6,30]]},"reference":[{"key":"key-10.15585\/mmwr.mm7226a3-202306291024-R1","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.30297","article-title":"Estimating prevalence of hepatitis C virus infection in the United States, 2013\u20132016.","volume":"69","author":"Hofmeister","year":"2019","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.mm7226a3-202306291024-R2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.7326\/0003-4819-132-4-200002150-00008","article-title":"Pathogenesis, natural history, treatment, and prevention of hepatitis C.","volume":"132","author":"Liang","year":"2000","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.mm7226a3-202306291024-R3","unstructured":"US Department of Health and Human Services. Viral Hepatitis National Strategic Plan for the United States: a roadmap to elimination for the United States, 2021\u20132025. Washington, DC: US Department of Health and Human Services; 2020. https:\/\/www.hhs.gov\/sites\/default\/files\/Viral-Hepatitis-National-Strategic-Plan-2021-2025.pdf"},{"key":"key-10.15585\/mmwr.mm7226a3-202306291024-R4","doi-asserted-by":"publisher","DOI":"10.1177\/00333549231170044","article-title":"Development of a standardized, laboratory result-based hepatitis C virus clearance cascade for public health jurisdictions.","author":"Montgomery","year":"2023","journal-title":"Public Health Rep"},{"key":"key-10.15585\/mmwr.mm7226a3-202306291024-R5","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/hep.31060","article-title":"Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases\u2013Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection","volume":"71","author":"Ghany","year":"2020","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.mm7226a3-202306291024-R6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.7326\/M16-2575","article-title":"Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review.","volume":"166","author":"Falade-Nwulia","year":"2017","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.mm7226a3-202306291024-R7","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1001\/jama.2023.3692","article-title":"A national hepatitis C elimination program in the United States: a historic opportunity.","volume":"329","author":"Fleurence","year":"2023","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.mm7226a3-202306291024-R8","doi-asserted-by":"publisher","first-page":"ofac445","DOI":"10.1093\/ofid\/ofac445","article-title":"The hepatitis C care cascade during the direct-acting antiviral era in a United States commercially insured population.","volume":"9","author":"Ferrante","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"key-10.15585\/mmwr.mm7226a3-202306291024-R9","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.15585\/mmwr.mm7132e1","article-title":"Vital signs: hepatitis C treatment among insured adults\u2014United States, 2019\u20132020.","volume":"71","author":"Thompson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T14:43:41Z","timestamp":1688049821000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/72\/wr\/mm7226a3.htm?s_cid=mm7226a3_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,30]]},"references-count":9,"journal-issue":{"issue":"26","published-online":{"date-parts":[[2023,6,30]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm7226a3","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6,30]]},"published":{"date-parts":[[2023,6,30]]}}}